Literature DB >> 6124269

Effect of microsomally activated AFB1 on GGT activity in 3 rat liver cell lines.

M M Manson, J A Green.   

Abstract

Three cell lines derived from adult rat liver have been used to study changes in levels of gamma-glutamyl transferase (GGT), a possible marker for premalignant transformation in liver in vivo. None of the cell lines was able to metabolize aflatoxin B1 (AFB1) and treatment with AFB1 alone did not influence GGT activity. However, treatment with microsomally activated AFB1 increased the level of activity in a cell line (BL8L) derived from normal liver with very low levels of GGT, by as much as 10-fold, and 5-fold in a cell line (ARL) also isolated from normal rat liver, but which had subsequently undergone spontaneous transformation. Microsomes from rats pretreated with phenobarbitone were compared with those from 3-methylcholanthrene-treated animals. AFB1 activated by the former produced larger increases in GGT activity, but in no case did the enzyme levels approach that in a cell line (JBI) derived from a hepatoma in the liver of an AFB1-fed rat. Treatment of JBI cells with microsomally activated AFB1 produced no further increase in activity. Histochemical staining indicated an uneven distribution of enzyme in all cell populations, both before and after treatment. This cell-culture system is useful for further studies on the role of GGT in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124269      PMCID: PMC2011051          DOI: 10.1038/bjc.1982.147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Gamma-glutamyl transpeptidase: a positive marker for cultured rat liver cells derived from putative premalignant and malignant lesions.

Authors:  B A Laishes; K Ogawa; E Roberts; E Farber
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

2.  gamma-Glutamyltranspeptidase activity in normal, regenerating and malignant hepatocytes.

Authors:  S Cheng; K Nassar; D Levy
Journal:  FEBS Lett       Date:  1978-01-15       Impact factor: 4.124

3.  Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis.

Authors:  M M Kalengayi; G Ronchi; V J Desmet
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

4.  In vitro transformation of Syrian hamster embryo cells by diverse chemical carcinogens.

Authors:  J A DiPaolo; R L Nelson; P J Donovan
Journal:  Nature       Date:  1972-02-04       Impact factor: 49.962

5.  Carcinoma after malignant conversion in vitro of epithelial-like cells from rat liver following exposure to chemical carcinogens.

Authors:  G M Williams; J M Elliott; J H Weisburger
Journal:  Cancer Res       Date:  1973-03       Impact factor: 12.701

6.  In vitro malignant transformation of cells derived from rat liver by means of aflatoxin B1.

Authors:  K Toyoshima; Y Hiasa; N Ito; Y Tsubura
Journal:  Gan       Date:  1970-12

7.  Development of resistance to cytotoxicity during aflatoxin carcinogenesis.

Authors:  D J Judah; R F Legg; G E Neal
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

8.  A diploid rat liver cell culture. IV. Malignant transformation by aflatoxin B1.

Authors:  W I Schaeffer; N H Heintz
Journal:  In Vitro       Date:  1978-05

9.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

10.  Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms.

Authors:  G M Williams; T Ohmori; S Katayama; J M Rice
Journal:  Carcinogenesis       Date:  1980       Impact factor: 4.944

View more
  1 in total

1.  Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1.

Authors:  E J Moss; D J Judah; M Przybylski; G E Neal
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.